Drug Profile
Eptotermin alfa - Olympus Biotech
Alternative Names: Opgenra; OsigraftLatest Information Update: 24 Jan 2019
Price :
$50
*
At a glance
- Originator Olympus Biotech Europe SAS
- Class Bone morphogenetic proteins; Calcium regulators; Osteoporosis therapies; Recombinant proteins
- Mechanism of Action Apoptosis inhibitors; Collagen stimulants; Matrix metalloproteinase 13 modulators; Proteoglycan stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Non-union fracture; Spondylolisthesis
Most Recent Events
- 24 Jan 2019 Eptotermin alfa is not yet available for Spondylisthesis (In adults) in Iceland, Norway and Liechtenstein (Implant)